🎯 Treat-to-Target (T2T) is revolutionizing #IBD care — aiming beyond symptom control toward deep remission using objective markers like biomarkers, endoscopy, and histology. ✅ Benefits? 💡Higher mucosal healing 💡Fewer complications 💡Personalized, proactive therapy ⚠️ But don’t forget the challenges: 🚫Resource demands 🚫Adherence issues 🚫Cost & access disparities 🚫Standardization gaps Let’s move forward with T2T — but thoughtfully and equitably. #TreatToTarget #IBDcare #STRIDE #PrecisionMedicine

🌼As a first-year Gastroenterology fellow, you're embarking on an exciting journey in a specialized field of medicine 🌼Here are some advice and tips to help you navigate your first year successfully! 🌼Remember, the first year of fellowship is just the beginning of your journey 🌼Embrace the challenges, stay curious, and continue to learn and grow as a gastroenterologist @AmCollegeGastro @AmerGastroAssn @AASLDtweets @CrohnsColitisFn @ASGEendoscopy @GIOnDEMAND @Gastro_Network @AmerMedicalAssn @ACPIMPhysicians

Dr Adnan Altaf will be presenting today "IBD in pediatrics" to physicians of Pakistan through our joint @southasianIBD and @PARSAECHOpk project.